FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

Submitted by admin on June 2, 2024 - 2:50pm
Source: 
Reuters
News Tags: 
Moderna Therapeutics
FDA
RSV
vaccines
Headline: 
FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
snippet: 

The U.S. Food and Drug Administration approved Moderna's (MRNA.O) respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Do Not Allow Advertisers to Use My Personal information